For the last three issues of Electromagnetics
Forum, each issue carried many different articles
on the various aspects of the health effects of
electromagnetic fields/radiation. For this particular
issue I have digressed from that format to examine
the evidence for a connection with powerline
electromagnetic fields, melatonin and breast cancer.
This issue, which has for the several months taken up
much of my time, has resulted in my latest report
being tabled in the Australian Senate on 29 October
1997.
Since the incorporation of this report in the
Senate Hansard , there have been numerous enquiries,
both in Australia and overseas for this report. The
most effective way to meet these requests in a
"reader friendly" way is to incorporate the
report, Senator Lyn Allison's speech and related
information into this newsletter. Some of the
information in the senate report has been printed in
previous issues of Electromagnetics Forum, my
apologies to my readers for the repetition.
The senate report, far from being unwarranted,
details overseas mainstream research which
unfortunately remains largely unknown to either
Australian medical practitioners working with breast
cancer patients or the medical fraternity in general.
The relevance of this information for breast cancer
treatment is clearly mentioned in the latest
scientific publication reviewing this issue.
To quote from the preface of The Melatonin
Hypothesis: Breast Cancer and Use of Electric Power,
edited by Richard Stevens, Bary Wilson and Larry
Anderson, from the Pacific Northwest Laboratory,
operated by Battelle Memorial Institute for the
United States Department of Energy, Published by the
Battelle Press in 1997.
"Our group itself has, by design, included
researchers from a wide range of disciplines. From
this rich diversity of experience came the
"Melatonin Hypothesis." With its basis in
the modest and, at the time, arcane nocturnal
experiments of almost 20 years ago, this hypothesis
has become one of the salient hypotheses on breast
cancer etiology in the main cancer research
community."
Unfortunately to date none of the research money
set aside for breast cancer research in Australia is
examining this topic for reasons outlined in my
report. It is my hope that the tabling of this report
in the senate will lead to a change in this omission.